ALYSSA PETERSON: Open Payments
NPI 1437743507 · BROOKINGS, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$716 in 37 payments from 11 companies in 2025. Trend: 2023 $850 · 2024 $1,682 · 2025 $716
Food & beverage: $716
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 15 | $236 |
| Stryker Corporation | 3 | $130 |
| Teva Pharmaceuticals USA, Inc. | 4 | $78 |
| Neurocrine BioSciences, Inc. | 4 | $71 |
| Corium, LLC | 4 | $65 |
| Vanda Pharmaceuticals Inc. | 1 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $30 |
| Alkermes, Inc. | 1 | $23 |
| Tris Pharma Inc | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
Products named: REXULTI, N/A, INGREZZA, Azstarys, UZEDY, FANAPT, CAPLYTA, ARISTADA.
Industry payments across SD — which companies pay providers there.
